Anthem Biosciences Limited (ANTHEM) — Board Meeting | 24 July 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
45th AGM passed all 8 resolutions including financials and appointments
💡 Investor Takeaway
Shareholders backed all governance and financial proposals with strong majorities, signaling confidence in management continuity.

Anthem Biosciences held its 45th AGM on July 22, 2026, approving all 8 resolutions including audited financial statements, dividend declaration, director appointments, auditor selection, and related party remuneration. Shareholders endorsed key governance and compensation measures with overwhelming majorities, reflecting strong stakeholder alignment on operational continuity and financial transparency.

📄 View Original Announcement (PDF)

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹53,084.93 Cr P/E: 91.9 ROE: 18.9% ROCE: 25.5% Div Yield: 0.21%

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day